Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Using an index divisor in calculations helps maintain consistent measurements when prices or shares change, enabling fair comparisons.
22,117 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A new round of US-China diplomacy has arrived, but Taiwan's chip giant TSMC remains in the crosshairs. Investors are ...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Mortgage lenders race to own the first online touchpoint to win borrowers. Independent digital branding is becoming a...
Target rolls out a broad turnaround, including redesigned carts and a baby concierge service, but investors question ...
Harvard's Faculty of Arts and Sciences approved a move to limit A grades for undergraduates, signaling a major bid to...
Micron reports robust Q3 guidance and signs a five-year strategic deal, fueling optimism that the AI memory cycle cou...
A bold policy idea could reshape how the U.S. handles digital assets. This article explains the proposed ARMA bill ai...
A 30-something investor reveals a heavy tilt toward Vanguard's Information Technology ETF, raising questions about di...
Palo Alto Networks is outperforming Palantir this year, driven by AI-native security demand and margin gains, while i...
A renewed bond market selloff is sharpening focus on fiscal risks. Analysts say the u.s. debt ‘elephant room’ could q...
Bitcoin steadies in the upper $77,000s as markets weigh renewed U.S.-Iran talks. Oil prices and Fed pricing will dete...